Center for Lymphoid Malignancies at CUMC

New York, New York 10019

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Lymphoma, T-Cell Clinical Trial
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Center for Lymphoid Malignancies at CUMC
mi
from
New York, NY
Click here to add this to my saved trials
Lymphoma, T-Cell, Peripheral Clinical Trial
Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL
Status: Upcoming, Phase III
Updated: 3/7/2018
Center for Lymphoid Malignancies at CUMC
mi
from
New York, NY
Click here to add this to my saved trials